Literature DB >> 8876133

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

P Marconi1, D Krisky, T Oligino, P L Poliani, R Ramakrishnan, W F Goins, D J Fink, J C Glorioso.   

Abstract

Mesh：

Year:  1996        PMID： 8876133      PMCID： PMC38055          DOI： 10.1073/pnas.93.21.11319

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  12 in total

1.  Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2.

Authors:  P A Schaffer; V C Carter; M C Timbury
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

2.  Control of mRNA stability by the virion host shutoff function of herpes simplex virus.

Authors:  A A Oroskar; G S Read
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.

Authors:  I A York; C Roop; D W Andrews; S R Riddell; F L Graham; D C Johnson
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

4.  Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient.

Authors:  A M McCarthy; L McMahan; P A Schaffer
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function.

Authors:  P A Johnson; M J Wang; T Friedmann
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 6.  Gene transfer to neurons using herpes simplex virus-based vectors.

Authors:  D J Fink; N A DeLuca; W F Goins; J C Glorioso
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

7.  Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1.

Authors:  P A Johnson; A Miyanohara; F Levine; T Cahill; T Friedmann
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

8.  Long-term promoter activity during herpes simplex virus latency.

Authors:  J R Lokensgard; D C Bloom; A T Dobson; L T Feldman
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

9.  Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.

Authors:  J C Mester; P M Pitha; J C Glorioso
Journal:  Gene Ther       Date:  1995-05       Impact factor: 5.250

10.  Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.

Authors:  N A DeLuca; A M McCarthy; P A Schaffer
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103
View more
  31 in total

1.  Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.

Authors:  D B Anderson; S Laquerre; K Ghosh; H P Ghosh; W F Goins; J B Cohen; J C Glorioso
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 3.  Virus-based gene delivery systems.

Authors:  Cathryn Mah; Barry J Byrne; Terence R Flotte
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

5.  An HSV vector system for selection of ligand-gated ion channel modulators.

Authors:  Rahul Srinivasan; Shaohua Huang; Suchita Chaudhry; Adrian Sculptoreanu; David Krisky; Michael Cascio; Peter A Friedman; William C de Groat; Darren Wolfe; Joseph C Glorioso
Journal:  Nat Methods       Date:  2007-08-05       Impact factor: 28.547

Review 6.  Immune responses to herpesviral vectors.

Authors:  Deborah A Ryan; Howard J Federoff
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

Review 7.  Herpes simplex viral vectors: late bloomers with big potential.

Authors:  Joseph C Glorioso
Journal:  Hum Gene Ther       Date:  2014-02       Impact factor: 5.695

8.  Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.

Authors:  R Kato; D Wolfe; C H Coyle; J B Wechuck; P Tyagi; T Tsukamoto; J B Nelson; J C Glorioso; M B Chancellor; N Yoshimura
Journal:  Gene Ther       Date:  2008-07-31       Impact factor: 5.250

9.  Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.

Authors:  Hitoshi Yokoyama; Tomohiko Oguchi; William F Goins; James R Goss; Osamu Nishizawa; William C de Groat; Darren Wolfe; David M Krisky; Joseph C Glorioso; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2013-02-14       Impact factor: 5.695

10.  Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.

Authors:  W F Goins; K A Lee; J D Cavalcoli; M E O'Malley; S T DeKosky; D J Fink; J C Glorioso
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.